<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">mouse</item><item key="factors"><item><item key="GSM995429"><item key="COMPOUND">vehicle</item></item></item><item><item key="GSM995429"><item key="COMPOUND">vehicle</item></item></item><item><item key="GSM995429"><item key="COMPOUND">vehicle</item></item></item><item><item key="GSM995432"><item key="COMPOUND">CDK4/6 inhibitor PD 0332991</item></item></item><item><item key="GSM995432"><item key="COMPOUND">CDK4/6 inhibitor PD 0332991</item></item></item><item><item key="GSM995432"><item key="COMPOUND">CDK4/6 inhibitor PD 0332991</item></item></item></item><item key="id">7001</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">6</item><item key="summary_wrapped">D-cyclins represent components of cell cycle machinery. To test the efficacy of targeting D-cyclins in cancer treatment, we engineered...</item><item key="geo_gse_id">E-GEOD-40513</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">6</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">gene-expression-profile-of-mouse-breast-cancer-v72</item><item key="geo_id_plat">E-GEOD-40513_A-AFFY-45</item><item key="name">Gene expression profile of mouse breast cancer V720 cells treated with vehicle or PD 0332991</item><item key="created">Nov.12, 2014</item><item key="summary">D-cyclins represent components of cell cycle machinery. To test the efficacy of targeting D-cyclins in cancer treatment, we engineered mouse strains which allow acute and global ablation of individual D-cyclins in a living animal. Ubiquitous shutdown of cyclin D1 or inhibition of cyclin D associated kinase activity in mice bearing ErbB2-driven mammary carcinomas halted cancer progression and triggered tumor-specific senescence, without compromising the animals' health. Ablation of cyclin D3 in mice bearing T-cell acute lymphoblastic leukemias (T-ALL) triggered tumorspecific apoptosis. Such selective killing of leukemic cells can be also achieved by inhibiting cyclin D associated kinase activity in mouse and human T-ALL models. Hence, contrary to what one might expect from ablation of a cell cycle protein, acute shutdown of a D-cyclin leads not only to cell cycle arrest, but it also triggers tumor cell senescence or apoptosis, and it affects different tumor types through distinct cellular mechanisms. Inhibiting cyclin D-activity represents a highly-selective anticancer strategy which specifically targets cancer cells without significantly affecting normal tissues. Mouse breast cancer V720 cells were cultured in the presence of the CDK4/6 inhibitor PD 0332991 (PD; 1 microM) or vehicle (VO) for 24 hrs. Experiment was done in biological triplicate. A total of 6 RNA samples (3 vehicle treated and 3 PD 0332991 treated samples) were used for microarray expression analysis.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-40513</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-40513/samples/</item></data></biogps>
